/raid1/www/Hosts/bankrupt/TCR_Public/240706.mbx          T R O U B L E D   C O M P A N Y   R E P O R T E R

              Saturday, July 6, 2024, Vol. 28, No. 187

                            Headlines

ACORDA THERAPEUTICS: Narrows Net Loss to $5.6 Million in May
EBIX INC: Widens Net Loss to $11.5 Million in May
EIGER BIOPHARMACEUTICALS: Posts $21.27 Million Net Loss in May
SVB FINANCIAL: Posts $24.88 Million Net Loss in May

                            *********

ACORDA THERAPEUTICS: Narrows Net Loss to $5.6 Million in May
------------------------------------------------------------
Acorda Therapeutics Inc. filed with the U.S. Securities and
Exchange Commission its monthly operating report for May 2024.

The Debtor's statement of operations reflected a net loss of $5.6
million for the current period, a significant decrease from the
$20.8 million net loss in April.

As of May 31, 2024, the Debtor listed $546 million in total assets,
$259.6 million in total liabilities, and $286.5 million in total
shareholders' equity.

The Debtor started the month with $12.2 million cash. It listed
total cash receipts of $12.4 million and total disbursements of
$7.2 million. At month end, the Debtor had $17.5 million cash.

A copy of the monthly operating report is available at the SEC at:

               https://tinyurl.com/nvz5jary

                    About Acorda Therapeutics

Acorda Therapeutics Inc. is a biopharmaceutical company that has
developed breakthrough products, therapies, and biotechnology to
restore function and improve the lives of people with neurological
disorders. INBRIJA is approved for intermittent treatment of OFF
episodes in adults with Parkinson's disease treated with
carbidopa/levodopa.

Acorda Therapeutics Inc. and its affiliates sought relief under
Chapter 11 of the U.S. Bankruptcy Code (Bankr. S.D.N.Y. Lead Case
No. 24-22284) on April 1, 2024.  In the petition signed by Michael
A. Gesser, as chief financial officer, the Debtor disclosed total
assets as of Dec. 31, 2023, of $108,525,000 and total debt as of
Dec. 31, 2023, of $266,204,000.

The Honorable Bankruptcy Judge David S. Jones handles the case.

The Debtor tapped Baker McKenzie as legal counsel; Togut, Segal &
Segal LLP as conflicts counsel; Ernst & Young as financial advisor;
and Ducera Partners and Leerink Partners as investment bankers.
Kroll Restructuring Administration is the claims agent.

Merz is being advised by Freshfields Bruckhaus Deringer US LLP as
legal counsel, Morgan Stanley as investment banker, and Deloitte as
financial and tax advisors.  Senior Convertible Noteholders are
being advised by King & Spalding as legal counsel and Perella
Weinberg Partners as investment banker.

The U.S. Trustee for Region 2 appointed an official committee to
represent unsecured creditors in the Debtors' Chapter 11 cases.


EBIX INC: Widens Net Loss to $11.5 Million in May
-------------------------------------------------
Ebix Inc. filed with the U.S. Securities and Exchange Commission
its monthly operating report for May 2024.

The Debtor's statement of operations reflected a net loss of $11.5
million for May, compared to a net loss of $5.4 million in April.

As of May 31, 2024, the Debtor listed $547.9 million in total
assets, $1.1 billion in total liabilities, and -$515.6 million in
total shareholders' equity.

The Debtor started the month with $10.4 million cash. It listed
total cash receipts of $21.7 million and total disbursements of
$19.8 million. At month end, the Debtor had $12.3 million cash.

A copy of the monthly operating report is available at the SEC at:

                https://tinyurl.com/33mww28k

                  About Ebix, Inc.

Ebix Inc. -- https://www.ebix.com/ -- is headquartered in Atlanta,
Ga., and it supplies software and electronic commerce solutions to
the insurance industry. With approximately 200 offices across six
continents, Ebix, (NASDAQ: EBIX) endeavors to provide on-demand
infrastructure exchanges to the insurance, financial services,
travel and healthcare industries.

Ebix and its affiliates filed Chapter 11 petitions (Bankr. N.D.
Texas Lead Case No. 23-80004) on Dec. 17, 2023.  At the time of the
filing, Ebix reported between $500 million and $1 billion in both
assets and liabilities.

Judge Scott W. Everett oversees the cases.

The Debtors tapped Sidley Austin, LLP as bankruptcy counsel;
Alixpartners, LLP as financial advisor; and Jefferies, LLC as
investment banker.  Omni Agent Solutions, Inc. is the claims
agent.

The U.S. Trustee for Region 6 appointed an official committee to
represent unsecured creditors in the Debtors' Chapter 11 cases. The
committee is represented by McDermott Will & Emery, LLP.


EIGER BIOPHARMACEUTICALS: Posts $21.27 Million Net Loss in May
--------------------------------------------------------------
Eiger BioPharmaceuticals, Inc. filed with the U.S. Securities and
Exchange Commission its monthly operating report for May 2024.

The Debtor's statement of operations reflected a net loss of $21.27
million for the current reporting period.

As of May 31, 2024, the Debtor listed $56.5 million in total
assets, $50.17 million in total liabilities, and $6.33 million in
total shareholders' equity.

The Debtor started the month with $11.96 million cash. It listed
total cash receipts of $25.25 million, and total disbursements of
$4.85 million. At month end, the Debtor had $32.36 million cash.

A copy of the monthly operating report is available at the SEC at:

                https://tinyurl.com/y2dneu4m

              About Eiger BioPharmaceuticals

Palo Alto, California-based Eiger BioPharmaceuticals, Inc., is a
commercial-stage biopharmaceutical company focused on the
development of innovative therapies for rare metabolic diseases.
The company's shares traded on Nasdaq under the symbol "EIGR".

Eiger Biopharmaceuticals Inc. and its subsidiaries sought relief
under Chapter 11 of the U.S. Bankruptcy Code (Bankr. N.D. Texas
Lead Case No. 24-80040) on April 1, 2024. In its petition, Eiger
listed $38.8 million in assets and $53.1 million in liabilities as
of the bankruptcy filing.

Judge Stacey G. Jernigan oversees the cases.

The Debtors are represented by Sidley Austin LLP as legal counsel,
Alvarez & Marsal as financial advisor and SSG Capital Advisors, LLC
as restructuring investment banker. Kurtzman Carson Consultants LLC
is the claims agent.


SVB FINANCIAL: Posts $24.88 Million Net Loss in May
---------------------------------------------------
SVB Financial Group filed with the U.S. Securities and Exchange
Commission its monthly operating report for May 2024.

The Debtor's statement of operations reflected a net loss of $24.88
million in the current reporting period.

As of May 31, 2024, the Debtor listed $3.57 billion in total
assets, $3.53 billion in total liabilities, and $4.63 million in
total shareholders' equity.

The Debtor started the month with $197.27 million cash. It listed
total cash receipts of $71.83 million and total disbursements of
$53.5 million. At month end, the Debtor had $215.6 million cash.

A copy of the monthly operating report is available at the SEC at:

               https://tinyurl.com/bddbwyrz

                About SVB Financial Group

SVB Financial Group is a financial services company focusing on the
innovation economy, offering financial products and services to
clients across the United States and in key international markets.


Prior to March 10, 2023, SVB Financial Group owned and operated
Silicon Valley Bank, a state-chartered bank.  During the week of
March 6, 2023, Silicon Valley Bank, Santa Clara, CA, experienced a
severe "run-on-the-bank."  On the morning of March 10, the
California Department of Financial Protection and Innovation seized
SVB and placed it under the receivership of the Federal Deposit
Insurance Corporation.  SVB was the nation's 16th largest bank and
the biggest to fail since the 2008 financial meltdown.

On March 17, 2023, SVB Financial Group sought Chapter 11 bankruptcy
protection (Bankr. S.D.N.Y. Case No. 23-10367). The Debtor had
assets of $19,679,000,000 and liabilities of $3,675,000,000 as of
Dec. 31, 2022.

The Hon. Martin Glenn is the bankruptcy judge.

The Debtor tapped Sullivan & Cromwell, LLP as bankruptcy counsel;
Centerview Partners, LLC as investment banker; and Alvarez & Marsal
North America, LLC as restructuring advisor.  William Kosturos, a
partner at Alvarez & Marsal, serves as the Debtor's chief
restructuring officer.  Kroll Restructuring Administration, LLC, is
the claims and noticing agent and administrative advisor.

The U.S. Trustee for Region 2 appointed an official committee to
represent unsecured creditors in the Debtor's Chapter 11 case. The
committee tapped Akin Gump Strauss Hauer & Feld, LLP as bankruptcy
counsel; Cole Schotz P.C. as conflict counsel; Lazard Freres & Co.
LLC as investment banker; and Berkeley Research Group, LLC as
financial advisor.


                            *********

Monday's edition of the TCR delivers a list of indicative prices
for bond issues that reportedly trade well below par.  Prices are
obtained by TCR editors from a variety of outside sources during
the prior week we think are reliable.  Those sources may not,
however, be complete or accurate.  The Monday Bond Pricing table
is compiled on the Friday prior to publication.  Prices reported
are not intended to reflect actual trades.  Prices for actual
trades are probably different.  Our objective is to share
information, not make markets in publicly traded securities.
Nothing in the TCR constitutes an offer or solicitation to buy or
sell any security of any kind.  It is likely that some entity
affiliated with a TCR editor holds some position in the issuers
public debt and equity securities about which we report.

Each Tuesday edition of the TCR contains a list of companies with
insolvent balance sheets whose shares trade higher than $3 per
share in public markets.  At first glance, this list may look like
the definitive compilation of stocks that are ideal to sell short.
Don't be fooled.  Assets, for example, reported at historical cost
net of depreciation may understate the true value of a firm's
assets.  A company may establish reserves on its balance sheet for
liabilities that may never materialize.  The prices at which
equity securities trade in public market are determined by more
than a balance sheet solvency test.

On Thursdays, the TCR delivers a list of recently filed
Chapter 11 cases involving less than $1,000,000 in assets and
liabilities delivered to nation's bankruptcy courts.  The list
includes links to freely downloadable images of these small-dollar
petitions in Acrobat PDF format.

Each Friday's edition of the TCR includes a review about a book of
interest to troubled company professionals.  All titles are
available at your local bookstore or through Amazon.com.  Go to
http://www.bankrupt.com/books/to order any title today.

Monthly Operating Reports are summarized in every Saturday edition
of the TCR.

The Sunday TCR delivers securitization rating news from the week
then-ending.

TCR subscribers have free access to our on-line news archive.
Point your Web browser to http://TCRresources.bankrupt.com/and use
the e-mail address to which your TCR is delivered to login.

                            *********

S U B S C R I P T I O N   I N F O R M A T I O N

Troubled Company Reporter is a daily newsletter co-published
by Bankruptcy Creditors Service, Inc., Fairless Hills,
Pennsylvania, USA, and Beard Group, Inc., Philadelphia, Pa., USA.
Randy Antoni, Jhonas Dampog, Marites Claro, Joy Agravante,
Rousel Elaine Tumanda, Joel Anthony G. Lopez, Psyche A. Castillon,
Ivy B. Magdadaro, Carlo Fernandez, Christopher G. Patalinghug, and
Peter A. Chapman, Editors.

Copyright 2024.  All rights reserved.  ISSN: 1520-9474.

This material is copyrighted and any commercial use, resale or
publication in any form (including e-mail forwarding, electronic
re-mailing and photocopying) is strictly prohibited without prior
written permission of the publishers.  Information contained
herein is obtained from sources believed to be reliable, but is
not guaranteed.

The TCR subscription rate is $975 for 6 months delivered via
e-mail.  Additional e-mail subscriptions for members of the same
firm for the term of the initial subscription or balance thereof
are $25 each.  For subscription information, contact Peter A.
Chapman at 215-945-7000.

                   *** End of Transmission ***